Company / Operating Cash Flow per Share
Korro Bio, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$6.41
FY2025
5-year range
-$8.39 / $1.11
FY2021-FY2025
Trend
+23.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $-6.41.
Based on SEC 10-K filings.
-6.41 in FY2025.
Declined from $-2.20 to $-6.41 over the past 3 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 23.7% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.41 | +23.7% |
| FY2024 | -$8.39 | -281.9% |
| FY2022 | -$2.20 | -65.2% |
| FY2021 | -$1.33 | -219.9% |
| FY2020 | $1.11 | +115.8% |
| FY2019 | -$7.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026